Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Gastric Cancer. 2022 Jul;25(4):783-793. doi: 10.1007/s10120-022-01292-y. Epub 2022 Mar 30.
Gastric Cancer. 2022.
PMID: 35352176
Clinical Trial.
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.
Weiss GJ, Jameson G, Von Hoff DD, Valsasina B, Davite C, Di Giulio C, Fiorentini F, Alzani R, Carpinelli P, Di Sanzo A, Galvani A, Isacchi A, Ramanathan RK.
Weiss GJ, et al. Among authors: di sanzo a.
Invest New Drugs. 2018 Feb;36(1):85-95. doi: 10.1007/s10637-017-0491-7. Epub 2017 Jul 20.
Invest New Drugs. 2018.
PMID: 28726132
Clinical Trial.
Item in Clipboard
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas.
Vannata B, Vanazzi A, Negri M, Liptrott SJ, Bartosek AA, Miani M, Di Sanzo A, Cavalli F, Zucca E, Stathis A.
Vannata B, et al. Among authors: di sanzo a.
Hematol Oncol. 2021 Feb;39(1):60-65. doi: 10.1002/hon.2822. Epub 2020 Nov 6.
Hematol Oncol. 2021.
PMID: 33103778
Clinical Trial.
Item in Clipboard
Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.
Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group.
Marzona I, et al.
Acta Diabetol. 2017 Feb;54(2):123-131. doi: 10.1007/s00592-016-0899-0. Epub 2016 Oct 7.
Acta Diabetol. 2017.
PMID: 27718051
Item in Clipboard
n-3 fatty acids in patients with multiple cardiovascular risk factors.
Risk and Prevention Study Collaborative Group; Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R.
Risk and Prevention Study Collaborative Group, et al.
N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409.
N Engl J Med. 2013.
PMID: 23656645
Free article.
Clinical Trial.
Item in Clipboard
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Rischio and Prevenzione Investigators.
Rischio and Prevenzione Investigators.
Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68.
Trials. 2010.
PMID: 20509875
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite